NL
DE
The Department of Pharmacology and Toxicology has received Horizon 2020 funding for the creation of Paediatric Clinical Research Infrastructure Network (PedCRIN).
Radboudumc is partner in this 3.3. million euro project, which is coordinated by ECRIN the European Clinical Research Infrastructure Network.
Photo: Prof. Saskia de Wildt, Dept. of Clinical Pharmacology.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Grants for heart and kidney research Two awards to Radboudumc in Open Competition ENW-XS
21 July 2022Two researchers from the Radboudumc receive a grant from the NWO within the Open Competition of the Exact and Natural Sciences. They are Thijs Eijsvogels, who studies the heart, and Pieter Leermakers, who studies the kidneys.
read more
ZonMw grants to study optimal use of COVID-19 vaccines in patients with impaired immune systems
3 February 2021 How do people with reduced immunity, especially kidney patients, react to a COVID-19 vaccination? And how can patients with peripheral arterial disease be helped by DNA testing? Our researchers received grants from ZonMw to make these studies possible. read more
Transfer of new anti-hepatitis C drugs across the human placenta
9 September 2020 In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time. read more
Martinus van Marum prize for Tom Schirris
3 April 2020This award of € 12,500 is intended as an incentive prize for researchers who have obtained their PhD degree in 2015 or later. The jury, consisting of members of the Society, came to this decision unanimously.
read more
Differences in the placental disposition of TNF inhibitors uncovered
19 March 2020 In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept. read more
